Sign In
Buy XBI
$129.83
+2.07 (+1.62%)
At Close: Jun 03, 2026
3 Top Stock Trades for the Week
09:52am, Tuesday, 08'th Jun 2021
These three ETFs were red-hot on Monday, making them obvious choices for this week's top stock trades. Here's how to play them with options.
Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus
04:32pm, Tuesday, 01'st Jun 2021
Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.
7 Best Tech Index Funds for the Long-Haul Despite the Current Selloff
01:23pm, Monday, 24'th May 2021
The tech sector has been under pressure, but these seven index funds offer exposure to a range of tech shares and could become the building blocks of a successful growth portfolio. The post 7 Best Tec
5 All-Star ETFs & Stocks to Buy on the Dip
12:02pm, Wednesday, 19'th May 2021
As the U.S. economy is gaining momentum, the dips might charge investors to snap up stocks on the cheap, though they remained wary over inflation fears.
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines
06:02pm, Friday, 07'th May 2021
The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.
Buying This Beaten-Down ETF Could Make You a Fortune Over the Next 10 Years
05:52am, Friday, 07'th May 2021
It definitely made investors a lot of money over the last decade. And its future could be brighter than the past.
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus
04:32pm, Tuesday, 04'th May 2021
Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.
Options traders bet against S&P Biotech (XBI)
01:53pm, Tuesday, 04'th May 2021
"Halftime Report" trader Jon Najarian spots unusual activity in the options market
Best Biotech Stocks & ETFs for mRNA, Gene Editing
05:17pm, Thursday, 29'th Apr 2021
Here is what you should know about investing in these life changing technologies.
After Roaring In 2020, Biotech Stocks Now Weighed Down By Merger Scrutiny, FDA Approval Delays And Possible Drug Pricing Legislation
09:07am, Wednesday, 21'st Apr 2021
Biotech stocks surged last year in anticipation of a Covid vaccine and increased spending on healthcare by governments around the world, but a mix of regulatory factors are now pulling them back down.
Biotech Innovations Remain At Forefront
11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r
Moving Beyond COVID In Biopharma
09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus
06:10pm, Thursday, 08'th Apr 2021
Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.
Diagnosing The Future Of Healthcare
12:33pm, Thursday, 01'st Apr 2021
In our opinion, telehealth will remain the leading segment of the internet healthcare market as the market shifts away from in-person medical visits. According to Apple CEO Tim Cook, “I believe, if
Biotech is ‘the superhero of the pandemic': investor
02:44pm, Tuesday, 23'rd Mar 2021
Antoine Papiernik, managing partner at Sofinnova Partners, joins Yahoo Finance to discuss trends in biotech and impacts the pandemic had on scientific discoveries.
